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Background There is currently no standardized process for
long-term follow-up care. As a result, management of post-
stroke care varies greatly, and the needs of stroke survivors are
not fully addressed. The Post Stroke Checklist was developed
by the Global Stroke Community Advisory Panel as a means of
standardizing long-term stroke care. Since its development,
the Post Stroke Checklist has gained international recognition
from various stroke networks and is endorsed by the World
Stroke Organization to support improved stroke survivor
follow-up and care.
Aims The aim of this study was to evaluate the feasibility and
usefulness of the Post Stroke Checklist in clinical practice and
assess its relevance to stroke survivors in pilot studies in the
United Kingdom and Singapore.
Methods The Post Stroke Checklist was administered to stroke
survivors in the United Kingdom (n = 42) and Singapore
(n = 100) by clinicians. To assess the feasibility of the Post
Stroke Checklist in clinical practice, an independent researcher
observed the assessment and made notes relating to the
patient–clinician interaction and their interpretations of the
Post Stroke Checklist items. Patient and clinician satisfaction
with the Post Stroke Checklist was assessed by three ques-
tions, responded to on a 0–10 numerical rating scale. Clinicians
also completed a Pragmatic Face and Content Validity test to
evaluate their overall impressions of the Post Stroke Checklist.
In the United Kingdom, a subset of patients (n = 14) took part
in a concept elicitation interview prior to being administered
the Post Stroke Checklist, followed by a cognitive debriefing
interview to assess relevance and comprehension of the Post
Stroke Checklist.
Results The Post Stroke Checklist identified frequently
reported problems for stroke survivors including cognition
(reported by 47·2% of patients), mood (43·7%), and life after
stroke (38%). An average of 3·2 problems per patient was
identified across both countries (range 0–10). An average of 5
and 2·6 problems per patient were identified in the United
Kingdom and Singapore, respectively. The average time taken
to administer the Post Stroke Checklist was 17 mins (standard
deviation 7·5) in Singapore and 13 mins (standard deviation
7·6) in the United Kingdom. Satisfaction ratings were high for
patients (8·6/10) and clinicians (7·7/10), and clinician feedback
via the Pragmatic Face and Content Validity test indicated that
the Post Stroke Checklist is ‘useful’, ‘informative’, and ‘exhaus-
tive’. All concepts measured by the Post Stroke Checklist were
spontaneously discussed by patients during the concept elici-
tation interviews, suggesting that the Post Stroke Checklist is
relevant to stroke survivors. Cognitive debriefing data indi-
cated that the items were generally well understood and rel-
evant to stroke. Minor revisions were made to the Post Stroke
Checklist based on patient feedback.
Conclusions The findings suggest that the Post Stroke Check-
list is a feasible and useful measure for identifying long term
stroke care needs in a clinical practice setting. Pilot testing
indicated that the Post Stroke Checklist is able to identify a
wide range of unmet needs, and patient and clinician feedback
indicated a high level of satisfaction with the Post Stroke
Checklist assessment. The items were generally well under-
stood and considered relevant to stroke survivors, indicating
the Post Stroke Checklist is a feasible, useful, and relevant
measure of poststroke care.
Key words: assessment of health care needs, continuity of patient care,
long-term care, quality of life, referral and consultation, rehabilitation,
stroke
Introduction
The World Health Organization estimated that 15 million people
worldwide experience a stroke every year (1). Of these, a third are
left permanently disabled, impacting the patient’s quality of life,
as well as placing burdens on family, health systems, and the wider
community (1).
Following a stroke, patients can experience various long term
problems such as memory loss (2), spasticity (3), urinary incon-
tinence (4), pain (5), and cognitive impairment (6). These
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problems can result in a significant impact on the lives of patients
and contribute to an overall decrease in quality of life among
many patients, impacting their social relationships, emotional
well-being, physical functioning, and independence (7,8). A long-
term study conducted by Feigin et al. demonstrated that at five-
years post stroke, 29·3% of patients experienced depression,
22·5% had dementia, 15% had been institutionalized, and 20%
had experienced a recurrent stroke (9).
Despite the existence of national stroke strategies and guide-
lines for the management of post-stroke care [e.g. UK National
Stroke Strategy (10), NICE guideline (11), Singapore Ministry of
Health Stroke Clinical Practice guidelines (12)], there is cur-
rently no standardized process for long-term follow-up care. As a
result, knowledge and management of long-term poststroke care
varies greatly between clinicians (8) and national healthcare
systems (13), and the needs of patients are not fully addressed.
For example, a UK study reported that 49% of patients had
needs not addressed by healthcare providers, such as emotional
problems, fatigue, difficulties concentrating, and memory prob-
lems (14).
To address this gap, the Global Stroke Community Advisory
Panel (GSCAP), an international, multidisciplinary group of
stroke experts, developed the Post Stroke Checklist (PSC) (Fig. 1)
to help clinicians standardize the process of identifying long-term
problems and making appropriate treatment referrals (15).
Adopting a Delphi process, GSCAP identified key long-term
problem areas for stroke patients and reached a consensus on
which areas had the greatest impact on patients’ quality of life and
could be addressed by evidence-based interventions. Eleven post-
stroke problem areas were rated highly relevant to include in the
PSC: secondary prevention, activities of daily living (ADLs),
mobility, spasticity, pain, incontinence, communication, mood,
cognition, life after stroke, and relationship with caregiver (15).
The PSC has gained international recognition from various stoke
networks and advocacy groups and is endorsed by the World
Stroke Organization to support improved stroke survivor
follow-up and care (16).
Aims
The aim of this study was to evaluate the feasibility and usefulness
of the PSC in clinical practice and assess its relevance to stroke
survivors in two parallel PSC pilot studies in the United Kingdom
and Singapore.
Methods
Instrument
The PSC (15) is an 11-item checklist, administered by a clinician
to poststroke patients. Each item comprises a dichotomous ‘yes’/
‘no’ response scale and provides referral recommendations for
each problem identified.
Sample
Pilot studies were conducted in the United Kingdom and in Sin-
gapore between January 2012 and May 2013. In the United
Kingdom, participants were recruited from primary care practices
and a hospital stroke rehabilitation outpatient unit in Stoke-on-
Trent, Staffordshire. In Singapore, patients were recruited from
the Cognitive Outcomes After Stroke study, an ongoing investi-
gation of 400 stroke patients identified from the acute stroke
service (17). Clinicians at each site were invited to participate in
administrating the PSC to test its feasibility and usefulness across
various professions. A range of clinicians from various back-
grounds were targeted. Ethical approval was obtained from the
National Research Ethics Committee in the United Kingdom and
from the National Healthcare Group Domain Specific Review
Board in Singapore. Patients were eligible to participate if they
had experienced a cerebral infarction or intracerebral hemor-
rhage between 8 and 60 months ago (for UK patients) and
between 9 and 36 months ago (for Singapore patients). Expressive
dysphasic patients were included, provided they were able to
respond to the PSC items.
Procedure
The study was conducted in general practice clinics and a hospital
stroke unit in the United Kingdom and in a research facility in
Singapore. Prior to completing the PSC with patients, a researcher
provided training to the clinicians demonstrating how the PSC
should be administered.
Evaluation of the PSC involved a clinician administering the
checklist to patients on a one-to-one basis. During administration
of the PSC to all patients in the United Kingdom and English-
speaking patients in Singapore, a trained researcher was present in
the room, as an observer, to note any issues with the checklist
administration and record the duration of the assessment visit
and the time taken to administer the checklist. Following comple-
tion of the PSC, each patient completed a satisfaction question-
naire. Clinicians also completed a satisfaction questionnaire
following each assessment. At the end of each pilot, clinicians also
completed a Pragmatic Face and Content Validity test (PRAC-
Test) (18) to evaluate their overall impressions of the PSC.
In the United Kingdom, qualitative, face-to-face interviews
were also conducted with 14 patients. The interview was divided
into two segments: a 35-mins concept elicitation interview, to
explore the impact of stroke on patients’ lives (this was conducted
immediately prior to PSC administration) and a 45-mins cogni-
tive debriefing interview [a qualitative research tool used to deter-
mine whether concepts and items are understood by patients in
the same way that instrument developers intend (19)] to explore
the comprehensibility and relevance of PSC items to patients (this
was conducted immediately following PSC administration).
Research outcomes
Feasibility of PSC administration in clinical practice
The feasibility of the PSC was assessed quantitatively by examin-
ing the time taken to complete the checklist and the frequency
distribution of responses.
Patient comprehension and relevance of the PSC (face and
content validity)
Comprehension of the PSC was assessed qualitatively in terms of
the consistency of interpretations of each item between clinicians
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Fig. 1 Post Stroke Checklist (PSC).
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and patients and any issues noted with the PSC, identified
through observer notes and the cognitive debriefing interviews.
The relevance of the PSC was assessed from data collected during
concept elicitation and cognitive debriefing interviews.
Satisfaction with the PSC
Satisfaction was assessed by clinician-completed and patient-
completed satisfaction questionnaires, which asked participants
to rate their satisfaction with the checklist across three items, each
measured on a 0–10 numerical rating scale. Specifically, satisfac-
tion was rated in terms of satisfaction with the PSC assessment,
the ability of the PSC to correctly identify patient’s needs, the
perceived likelihood of receiving the required health care services
(for patients only), and how helpful the PSC was in determining
referrals (for clinicians only). Clinicians also completed the
PRAC-Test at the end of the study to assess their overall views
about the PSC.
Amendments to the PSC
All data collected during the pilots were used to update the PSC
content, wording and format. This information will also be used
to aid the development of a patient-completed version of the PSC.
Analysis
Quantitative data collected from the PSC, the patient and clini-
cian satisfaction questionnaires, and PRAC test were summarized
using descriptive statistics. Interview transcripts were analyzed in
qualitative analysis software Atlas Ti (Scientific Software Devel-
opment GmbH, Berlin, Germany), using thematic analysis tech-
niques (20).
Results
Sample characteristics
Demographic and clinical information pertaining to the patient
sample are presented in Table 1. The average age of patients was
63 years [standard deviation (SD) 11·2; range 24–95 years]. The
majority of patients were male (72·5%), and most suffered from
at least one comorbidity, with cardiovascular disease the most
frequently reported (78%).
The UK pilot involved three practice nurses, two research
nurses, two general practitioners, one occupational therapist and
a stroke consultant. The Singapore pilot involved five research
coordinators, two research fellows, two stroke specialists and a
research rater.
Feasibility of the PSC
The PSC identified a wide range of unmet needs (Fig. 2). The
most frequently reported problem for patients was cognition,
reported by 47·2% of patients. Mood was also frequently
reported (43·7%), as was life after stroke (38%). Relationship
with caregiver was the least frequently reported problem,
reported by 19% of patients. The needs identified by the PSC
were consistent across both countries. An average of 3·2 prob-
lems per patient was identified across both countries (range
0–10). An average of 5 and 2·6 problems per patient were iden-
tified in the United Kingdom and Singapore, respectively
(Fig. 3). The average time taken to administer the PSC was
17 mins (SD 7·8) in Singapore and 13 mins (SD 7·6) in the
United Kingdom.
Table 1 Patient characteristic by study country
Patient characteristics Singapore (n = 100), n (%) UK (n = 42), n (%) Total (n = 142), n (%)
Age of patient
Mean (SD) 61 (10·9) 72 (8·1) 63 (11·2)
Min–Max 24–95 46–86 24–95
Missing/No response 1 (1) 3 (7·3) 4 (2·8)
Patient gender
Male 75 (75) 23 (54·8) 98 (69)
Female 25 (25) 17 (40·5) 42 (29·6)
Missing/No response 0 (0) 2 (4·8) 2 (1·4)
Time since most recent stroke (years)
Mean (SD) 1·1 (0·4) 1·7 (0·7) 1·3 (0·6)
Min–Max 0–2·9 0·4–3·3 0·0–3·3
Missing/No response 9 (9) 7 (16·7) 16 (11·3)
Current poststroke treatment*
Antiplatelet 81 (81) 13 (31) 94 (66·2)
Anticholesterol 36 (36) 18 (42·9) 54 (38)
Anticoagulant 6 (6) 5 (11·9) 11 (7·7)
Antihypertensive 38 (38) 17 (40·5) 55 (38·7)
Antihyperglycemic 18 (18) 1 (2·4) 19 (13·4)
Physical therapy 0 (0) 5 (11·9) 5 (3·5)
Occupational therapy 0 (0) 1 (2·4) 1 (0·7)
Speech and language therapy 0 (0) 1 (2·4) 1 (0·7)
Psychological therapy 0 (0) 3 (7·1) 3 (2·1)
Other 0 (0) 2 (4·8) 2 (1·4)
Missing data/No treatment 15 (15) 4 (9·5) 19 (13·4)
*The type of stroke experienced by patients was not recorded.
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Patient comprehension and relevance of the PSC (face
and content validity)
Observation of the PSC assessment indicated that the PSC items
were generally well understood by patients when read aloud to
them by the clinician. The cognitive debriefing interviews indi-
cated that patients generally understood and interpreted the items
as intended. In addition, the data indicated that the PSC items
were mostly relevant to patients, with most patients reporting that
they currently experience or have recently experienced the
impacts measured.
Most patients appeared to be using the correct recall period of
‘since your stroke or last assessment’ when answering the
questions.
Some patients attended the assessment with a family member
or carer, who also helped the patient respond to the PSC items. In
some of these cases, the carer interpreted the item in a different
manner to the patient, or disagreed with the patient’s response
and encouraged them to change their answer. In these instances,
the clinician marked down the patient’s final answer.
Observations of the PSC administration also indicated that the
items were interpreted consistently between clinicians. In some
instances, there was discordance between the clinicians’ and the
patients’ interpretation of certain items. This was particularly the
case for item 1 (‘Since your stroke or last assessment, have you
seen anyone regarding reducing the risk of another stroke?’),
where patients focused on appointments made specifically to
receive advice, whereas clinicians encouraged patients to think
about regular check-ups such as blood pressure and cholesterol
checks. In most cases, the patient changed their response when the
clinician clarified their interpretation of the item.
Patients spontaneously reported several symptoms and
impacts on different areas of daily life during the concept elicita-
tion interviews. The impacts discussed varied greatly between
patients. Frequently discussed post-stroke problems included
Fig. 2 Unmet needs identified with the Post Stroke Checklist.
Fig. 3 Number of referrals received per patient.
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physical impacts, such as mobility (n = 10) and pain (n = 9);
impacts on ADLs, such as preparing meals (n = 8) and housework
(n = 6); and the emotional impact, for instance feeling frustrated,
which appeared to be primarily related to a lack of independence,
and the inability to carry out daily tasks as achieved prior to the
stroke. All 10 symptom concepts assessed in the PSC were
spontaneously discussed by patients in the concept elicitation
interviews.
During concept elicitation, some concepts were mentioned by
patients that are not directly assessed in the PSC, including muscle
weakness, fatigue, loss of sensation, fine motor function, and
social behavior (see Fig. 4 for a comparison of the concepts elic-
ited in qualitative interviews, with those assessed in the PSC).
Despite not being directly measured, observation of the PSC
administration indicated that such concepts still arose when the
clinician went through the 11 PSC items with the patients, sug-
gesting that these are indirectly measured by the current PSC
items. Other concepts reported that are not currently measured in
the PSC included headache, dizziness, and weight gain, although
these were reported by just one patient each, suggesting they may
not be representative of the symptoms experienced by most stroke
survivors.
Satisfaction with the PSC
Patient satisfaction with the PSC assessment was high, with an
average rating of 8·6/10. Patient ratings of satisfaction that the
PSC identified their needs was also high; however, the data indi-
cated that patients believe they are not so likely to receive the
health and/or care needed (Fig. 5). Clinician satisfaction with the
PSC varied greatly between the patients they assessed; however,
satisfaction was generally high (Fig. 6). This suggests that the
variability of clinician satisfaction between patients is due to how
the PSC performs with individual patients rather than due to
individual clinicians.
In terms of clinician’s overall views of the PSC, their feedback
regarding the content and ease of use of the PSC (as measured
with the PRAC-Test) was generally positive, with most clinicians
indicating that the PSC is ‘useful’, ‘informative’, and ‘exhaustive’
(Fig. 7). These terms were endorsed by 9/10 clinicians, whereas
8/10 agreed that the PSC is ‘easy to explain’, ‘practical’, and
‘unbiased’.
Amendments to the PSC
The pilot studies identified some areas of improvement for
the PSC items. With this in mind, some items were reworded
Fig. 4 Conceptual model of poststroke impacts.
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based on the concepts discussed and language used by
patients during the qualitative interviews and the observed PSC
administrations.
For item 1 (‘Secondary Prevention’), there was inconsistency
between the patients’ interpretation of what constitutes ‘reducing
the risk of another stroke’; based on the observations for the PSC
administration and feedback during the cognitive debriefing
interviews, this was changed to ‘advice on changes to lifestyle or
medications for preventing another stroke’. For item 11 (‘Rela-
tionship with Caregiver’), one patient in Singapore misunder-
stood the term caregiver to mean his doctor. In the United
Kingdom, patients commented that this item was not relevant as
they did not consider themselves to have a caregiver. With this in
mind, the term ‘caregiver’ was reworded to ‘family’. These changes
were tested in 50/100 patients in Singapore, and the revised items
were well understood.
Discussion
The findings suggest that the PSC is a feasible and useful measure
for identifying long-term stroke care needs in a clinical practice
setting. Pilot testing indicated that the PSC is able to identify a
wide range of unmet needs; with cognition, mood, and life after
stroke being the most frequently identified issues for stroke sur-
vivors. Patient and clinician feedback indicated a high level of
satisfaction with the PSC assessment and its ability to correctly
identify their needs, though patients were slightly less confident
that they would receive the required services to target such needs.
Qualitative interviews with stroke patients, and observations of
the PSC assessment indicated that the PSC was generally well
understood by patients and considered relevant to their needs,
thus demonstrating face and content validity. Although there were
some issues with items 1 and 11, these seemed to be a result of
inconsistent interpretation between patients, as opposed to a lack
of understanding. Minor rewording of the two items appeared to
resolve these issues; testing of the revised measure in Singapore
elicited a more consistent understanding across the sample.
Qualitative interviews with post-stroke patients identified
some concepts not currently measured by the PSC, including
fatigue, muscle weakness, fine motor function, and social behav-
ior. The GSCAP members discussed potential item additions,
although given the purpose of the PSC is to be a concise referral
tool, which is both quick and easy to administer, the decision was
made to not add more items. This was primarily driven by two
factors: first, some concepts are not easily resolved by community
referrals, for instance fatigue. Second, observation of the PSC
administration indicated that the majority of additional concepts
discussed by patients are indirectly assessed by the current PSC
Fig. 5 Patient satisfaction with the Post Stroke Checklist.
Fig. 6 Clinician satisfaction with the Post Stroke Checklist.
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items; thus, it was felt that increasing the length of the PSC would
not be beneficial to patients or clinicians.
The mixed methods design utilized in this research has pro-
vided a comprehensive overview of the feasibility and usefulness
of the PSC in identifying poststroke needs. The authors recognize
that the sample size utilized in this study, though appropriate for
the study purposes, is not sufficient to invite cross-country
comparisons. It is anticipated that these findings will spur the
implementation of the PSC into larger stroke research studies
globally, which will allow such conclusions to be made.
One limitation of this research is that qualitative feedback was
obtained in the United Kingdom only and thus may not be
entirely representative of stroke survivors internationally. Quali-
tative work (in particular cognitive debriefing interviews) in addi-
tional countries, including Singapore, might strengthen the
evidence of the face and content validity of the PSC. In addition,
the Singapore pilot stipulated that patients must have experienced
a stroke within 9–60 months of the study, compared with 8–36
months for the UK pilot. The broader time permitted for the
Singapore pilot may have resulted in a more varied sample, in
terms of the symptoms and impacts experienced, and the severity
of such symptoms, which may have in turn influenced satisfaction
and PSC responses. However, it was felt that although different,
the time stipulated in both pilots was acceptable enough to allow
recruitment of a range of patients. For this pilot study, data
regarding stroke severity and lesion volume was not collected.
Further research may provide beneficial insights regarding
whether baseline factors such as stroke severity as measured by
the National Institute of Health Stroke Scale or lesion volume
affects the feasibility and usefulness of the PSC.
Presently, one of the limitations of the PSC is the time taken to
complete the assessment. Pilot testing indicated that the PSC
took, on average, longer to complete than a regular 10–15 mins
consultation. This therefore suggests that, at present, it may not be
possible to complete the full assessment within a regular consul-
tation. Clinicians should consider this factor when scheduling
post-stroke assessments and consider booking an extended
appointment, particularly if they are not familiar with the PSC. It
is, however, expected that with practice, clinicians will become
familiar with the items and the referrals, thus decreasing the time
needed for the PSC assessment over time. Moreover, patient-
completed version of the PSC is currently being developed. This
may be a useful alternative that can be completed prior to arriving
at the doctor’s office, or for patients who have difficulties travel-
ling to see their doctor in order to be assessed by the current
clinician-completed version.
Another limitation of the PSC is that it can only provide rec-
ommendations for treatment or further care; it is not capable of
enforcing follow-up care, and so it is up to the clinician to ensure
these are carried out. In addition, it is not yet known how different
healthcare systems will impact the implementation of the PSC
referrals; for instance, referrals may be more accessible to patients
in countries such as the United Kingdom and Canada, where
health care is free of charge, as opposed to countries where health
care is paid for privately by the patient. Work is currently ongoing
in the United Kingdom and Singapore to assess the outcomes of
the PSC assessment. Patient satisfaction with the referrals made
from the PSC is being evaluated, as well as the impact of the
referrals on patient’s quality of life, and their perceived level of
needs.
Fig. 7 Clinicians’ views of the Post Stroke Checklist.
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The PSC is currently being further implemented in various
practices across the United Kingdom, Singapore, United States,
and Canada, based on preliminary pilot results and several phy-
sician endorsements. It is hoped that the results of this study will
further encourage the implementation of the PSC globally, to
allow standardized strategies for stroke care to be implemented
across various healthcare systems to ultimately improve the lives
of stroke patients.
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